Agomelatine Improves Sleep in a Patient with Fatal Familial Insomnia

Abstract

A young patient with FFI was started on agomelatine 25 mg to medicate nocturnal insomnia. Under this treatment sleep efficiency was improved, slow wave sleep was high and awakenings during sleep period time were far less than before. Clinically the patient was less restless during nighttime.

Key words

dementia - insomnia - melatonin

• References

• 1 Harder A, Jendroska K, Kreuz F et al. Novel twelve-generation kindred of fatal familial insomnia from Germany representing the entire spectrum of disease expression. Am J Med Gen 1999; 87: 311-316
• 2 Lugaresi E, Medori R, Montagna P et al. Familial insomnia and dysautonomia with selective degeneration of thalamic nuclei. N Engl J Med 1986; 315: 997-1003
• 3 Hardeland R. New approaches in the management of insomnia: weighing the advantages of prolonged-release melatonin and synthetic melatoninergic agonists. Neuropsychiat Dis Treat 2009; 5: 341-354
• 4 Rechtschaffen A, Kales A. National Institutes of Health. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Publication no. 204, Neurological Information Network 1968;
• 5 Weidauer S, Gaa J, Neumann-Haefelin T et al. Posteriore Enzephalopathie: Neuroradiologische Befunde, Ursachen und klinischer Verlauf. Klin Neuroradiol 2003; 13: 34-44
• 6 Schenkein J, Montagna P. Self management of fatal familial insomnia. Part 1: what is FFI?. Med Gen Med 2006; 14: 65
• 7 Sforza E, Montagna P, Tinuper P et al. Sleep-wake cycle abnormalities in fatal familial insomnia. Evidence of the role of the thalamus in sleep regulation. Electroencephalogr Clin Neurophysiol 1995; 94: 398-405
• 8 Fuchs E, Simon M, Schmelting B. Pharmacology of a new antidepressant: benefit of the implication of the melatonergic system. Int Clin Psychopharmacol 2006; 21 (Suppl. 01) S17-S20
• 9 Kräuchi K, Cajochen C, Möri D et al. Early evening melatonin and S-20098 advance circadian phase and nocturnal regulation of core body temperature. Am J Physiol 1997; 272: R1178-R1188
• 10 Quera Salva MA, Vanier B, Laredo J et al. Major depressive disorder, sleep EEG and agomelatine: an open-label study. Int J Neuropsychopharmacol 2007; 10: 691-696
• 11 Drake Jr ME, Pakalnis A, Bogner JE et al. Outpatient sleep recording during antiepileptic drug monotherapy. Clin Electroencephalogr 1990; 21: 170-173
• 12 Legros B, Bazil CW. Effects of antiepileptic drugs on sleep architecture: a pilot study. Sleep Med 2003; 4: 51-55
• 13 Harding GF, Alford CA, Powell TE. The effect of sodium valproate on sleep, reaction times, and visual evoked potential in normal subjects. Epilepsia 1985; 26: 597-601
• 14 Ehrenberg BL, Eisensehr I, Corbett KE et al. Valproate for sleep consolidation in periodic limb movements disorder. J Clin Psychopharmacol 2000; 20 (Suppl. 05) S574-S578